Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different. LaHood A, Rahman R, McKenna L, Frick M, et al. PLoS One 2022;17:e0271102.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

LaHood A, Rahman R, McKenna L, Frick M, et al. Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different. PLoS One 2022;17:e0271102.
PMID: 35877601